The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has ...
We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. Eikon Therapeutics, Inc. (NASDAQ:EIKN) is one of the best up and coming stocks on our list. TheFly reported on ...
June’s IGN First is all about Final Fantasy XVI. Today, the development team at Square Enix are here to tell you all about the game’s powerful and flashy special moves, Eikonic Abilities. Check out ...
Hosted on MSN
Eikon Therapeutics to join Russell 3000 index
Eikon Therapeutics (EIKN) will be added to the Russell 3000 Index following the annual reconstitution, effective after the U.S. market closes on June 26. The Russell 3000 tracks about 3,000 U.S.
There are so many amazing Eikon Abilities in Final Fantasy 16 that it’s tough to know which ones you should spend your points on. This is especially in true in the early game when you don’t have many.
-Price (T.Rowe) U.S. Small-Cap Value Equity Trust 466.01k Mar 31, 2026 0.86% 4,930,396 T. Rowe Price Health Sciences Fund, Inc. 349.1k Mar 31, 2026 0.64% 3,693,456 T ...
MILLBRAE, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to ...
A high-level overview of Eikon Therapeutics, Inc. (EIKN) stock. View (EIKN) real-time stock price, chart, news, analysis, analyst reviews and more.
TheFly reported on June 3 that BofA Securities lowered its price target for EIKN to $32 from $34 while maintaining a Buy rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results